(Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -233.14%-53.09K | 23.00%-230.81K | 20.46%-45.12K | -1,166.40%-53.63K | 37.64%-116.13K | 69.69%-15.94K | -236.35%-299.76K | -56.73K | -4.24K | -186.22K |
Net income from continuing operations | -635.06%-170.79K | 16.16%-289.42K | 36.64%-47K | 21.67%-51.48K | -40.13%-167.71K | 72.87%-23.24K | -182.29%-345.22K | ---74.18K | ---65.73K | ---119.68K |
Asset impairment expenditure | ---- | --92.55K | --24.88K | ---18K | ---- | ---- | --0 | --0 | --0 | ---- |
Remuneration paid in stock | --103.61K | --0 | --0 | --0 | --0 | --0 | 220.35%55.9K | --1.86K | --108.08K | ---108.08K |
Other non cashItems | ---- | ---21.43K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 93.05%14.09K | -19.84%-12.51K | -110.06%-1.57K | 134.02%15.85K | -182.06%-34.09K | 134.79%7.3K | -166.38%-10.44K | --15.59K | ---46.59K | --41.54K |
-Change in receivables | 585.88%10.46K | -347.80%-17.81K | -242.34%-7.69K | 76.27%-3.75K | -155.21%-4.22K | -72.93%-2.15K | -10.84%-3.98K | --5.4K | ---15.78K | --7.65K |
-Change in prepaid assets | 50.03%2.6K | 49.97%-1.73K | -25.01%2.6K | 201.54%17.6K | -205.66%-23.67K | 114.44%1.73K | ---3.47K | --3.47K | ---17.33K | --22.4K |
-Change in payables and accrued expense | -86.66%1.03K | 335.12%7.04K | -47.67%3.52K | 114.81%2K | -153.93%-6.2K | 199.78%7.72K | -115.50%-2.99K | --6.73K | ---13.48K | --11.49K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -233.14%-53.09K | 23.00%-230.81K | 20.46%-45.12K | -1,166.40%-53.63K | 37.64%-116.13K | 69.69%-15.94K | -236.35%-299.76K | ---56.73K | ---4.24K | ---186.22K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -18K | 118.71%18K | -220.63%-48.09K | 0 | -96.19K | ||||
Net PPE purchase and sale | ---- | --0 | ---18K | 118.71%18K | ---- | ---- | -220.63%-48.09K | --0 | ---96.19K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | --0 | ---18K | 118.71%18K | ---- | ---- | -220.63%-48.09K | --0 | ---96.19K | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 153.38%288.5K | 0 | 0 | 0 | 153.38%288.5K | -84.33%113.86K | 0 | 227.72K | -227.72K |
Net common stock issuance | --0 | --288.5K | --0 | --0 | --0 | --288.5K | --0 | --0 | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%113.86K | --0 | --227.72K | ---227.72K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | 153.38%288.5K | --0 | --0 | --0 | 153.38%288.5K | -84.33%113.86K | --0 | --227.72K | ---227.72K |
Net cash flow | ||||||||||
Beginning cash position | 14.85%446.11K | -37.59%388.42K | 14.40%509.23K | -41.22%544.86K | -3.32%660.98K | -37.59%388.42K | --622.42K | --445.15K | --926.98K | --683.69K |
Current changes in cash | -119.48%-53.09K | 124.65%57.69K | -11.27%-63.12K | 92.60%-35.63K | -147.73%-116.13K | 344.79%272.56K | -137.59%-234K | ---56.73K | ---481.84K | --243.29K |
End cash Position | -40.54%393.02K | 14.85%446.11K | 14.85%446.11K | 14.40%509.23K | -41.22%544.86K | -3.32%660.98K | -37.59%388.42K | --388.42K | --445.15K | --926.98K |
Free cash from | -233.14%-53.09K | 33.65%-230.81K | 20.46%-45.12K | -2.49%-53.63K | 37.64%-116.13K | 69.69%-15.94K | -234.08%-347.86K | ---56.73K | ---52.33K | ---186.22K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data